INTEGRA LIFESCIENCES HOLDINGS CORP Stock Issued During Period, Value, New Issues
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- INTEGRA LIFESCIENCES HOLDINGS CORP stock issued during period, value, new issues for the quarter ending 2018-12-31 was $340.91M.
- INTEGRA LIFESCIENCES HOLDINGS CORP stock issued during period, value, new issues for the quarter ending 2018-09-30 was $5.50M.
- INTEGRA LIFESCIENCES HOLDINGS CORP stock issued during period, value, new issues for the quarter ending 2018-06-30 was $65.00K.
- INTEGRA LIFESCIENCES HOLDINGS CORP stock issued during period, value, new issues for the quarter ending 2018-03-31 was $3.11M, a 310900.00% increase year-over-year.
- INTEGRA LIFESCIENCES HOLDINGS CORP stock issued during period, value, new issues for fiscal 2018 was $349.59M, a 34958800.00% increase from fiscal 2017.
- INTEGRA LIFESCIENCES HOLDINGS CORP stock issued during period, value, new issues for fiscal 2017 was $1.00K.
- INTEGRA LIFESCIENCES HOLDINGS CORP stock issued during period, value, new issues for fiscal 2015 was $219.68M.
- INTEGRA LIFESCIENCES HOLDINGS CORP stock issued during period, value, new issues for fiscal 2013 was $152.46M.
| Period end | Stock Issued During Period, Value, New Issues 3 month | Stock Issued During Period, Value, New Issues 12 month |
|---|---|---|
| 2018-12-31 | $340.91M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-23 | $349.59M 10-K · filed 2021-02-23 |
| 2018-09-30 | $5.50M 10-Q · filed 2019-10-25 | |
| 2018-06-30 | $65.00K 10-Q · filed 2019-07-25 | |
| 2018-03-31 | $3.11M 10-Q · filed 2019-07-25 | |
| 2017-12-31 | $1.00K 10-K · filed 2018-03-01 | |
| 2017-03-31 | $1.00K 10-Q · filed 2018-11-01 | |
| 2015-12-31 | $219.68M 10-K · filed 2018-03-01 | |
| 2013-12-31 | $152.46M 10-K · filed 2016-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |
| Beta Bionics, Inc. (BBNX) | United States | $0.979B | -9.66 |
| Alphatec Holdings, Inc. (ATEC) | United States | $1.531B | -12.14 |
| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | United States | $1.535B | -9.02 |
| SpyGlass Pharma, Inc. (SGP) | United States | $0.925B | |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |